IOVA
Iovance Biotherapeutics, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$2.44
$-0.20
(-7.58%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $968.60M | EPS (ttm) | $-1.19 | Current Price | $2.44 |
| Enterprise Value | $799.69M | Forward EPS | $-0.60 | Previous Close | $2.64 |
| P/E Ratio | - | ROA | -27.12% | 52W High | $6.16 |
| Forward P/E | -4.05 | ROE | -53.89% | 52W Low | $1.64 |
| PEG Ratio | - | Gross Margin | 20.69% | 50 Day Avg | $2.49 |
| P/S Ratio | 3.87 | Operating Margin | -133.06% | 200 Day Avg | $2.36 |
| P/B Ratio | 1.34 | Profit Margin | -158.78% | Volume | 12.21M |
| EV/EBITDA | -2.13 | Current Ratio | 3.41 | Avg Volume | 13.88M |
| EV/Sales | 3.19 | Quick Ratio | 2.92 | Beta | 0.78 |
| Employees | 838.00 | Debt/Equity | 7.47 | Shares Outstanding | 396.97M |
| Sector | Healthcare | Total Debt | $52.49M | Float Shares | 338.65M |
| Industry | Biotechnology | Total Cash | $300.80M | Short Float | 31.83% |
| Optionable | Yes | Cash/Share | $0.76 | Short Ratio | 9.38 |
| Dividend Yield | - | Book Value/Share | $1.82 | % Held by Insiders | 0.32% |
| Target Price | $8.35 | Revenue (TTM) | $250.42M | % Held by Institutions | 61.88% |